Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance.

Acta gastro-enterologica Belgica

Volumn 76, Issue 1, 2013, Pages 34-37

  Köksal, Aydin Seref ^a   Onder, Fatih Oǧuz ^b   Torun, Serkan ^b   Parlak, Erkan ^b   Sayilir, Abdurrahim ^b   Tayfur, Oykü ^b   Yildiz, Hakan ^b   Ozbalci, Gökhan Selçuk ^b   Kayaçetin, Ertuǧrul ^b  

^a Department of Gastroenterology   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT; BISMUTH CITRATE; OMEPRAZOLE; ORGANOMETALLIC COMPOUND;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84879134445     PISSN: 00015644     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)